4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes
Key Takeaways
- Chest discomfort remains the most common presenting symptom of acute coronary syndrome in both sexes; women more frequently report additional associated symptoms such as dyspnea, nausea, fatigue, and jaw or back pain.
- Women are disproportionately affected by MINOCA, spontaneous coronary artery dissection, coronary microvascular dysfunction, and takotsubo syndrome — conditions that produce ischemia without obstructive epicardial disease.
- Women are referred to, enrolled in, and complete cardiac rehabilitation at lower rates than men despite deriving equivalent or greater mortality benefit.
- For Black adults without heart failure or chronic kidney disease, ACC/AHA guidance favors a thiazide-type diuretic or calcium channel blocker as initial antihypertensive therapy, and ACE-inhibitor angioedema risk is substantially higher.
- The 2018 AHA/ACC cholesterol guideline lists South Asian ancestry as a risk-enhancing factor that can favor initiating or intensifying statin therapy at borderline risk.
4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes
[!NOTE] Blueprint anchor: Domain 1 (Patient Assessment), task 1.10 — Describe signs and symptoms associated with cardiovascular diseases in diverse various patient populations (e.g., gender differences, racial differences).
Cardiovascular disease is the leading cause of death in women, yet it continues to be under-recognized, under-treated, and under-referred in women relative to men. Recognizing population-associated differences in presentation, pathophysiology, and treatment response is an assessment competency the CCRP exam tests directly.
[!IMPORTANT] A framing point that matters for both the exam and practice: race is a social construct, not a biological category. Where outcome differences by race appear, they are driven overwhelmingly by structural factors — access, referral patterns, environmental exposure, chronic stress, and discrimination — rather than by innate biology. A small number of pharmacologic response differences are described in guidelines and are worth knowing, but the correct interpretation of a racial disparity in outcomes is almost always structural.
Sex Differences in Acute Coronary Syndrome Presentation
A persistent and harmful oversimplification holds that women present with "atypical" symptoms and men present with chest pain. The evidence is more precise:
- Chest pain or discomfort is the most common presenting symptom in both sexes.
- Women more frequently report additional associated symptoms alongside the chest discomfort: dyspnea, nausea or vomiting, unusual fatigue, diaphoresis, palpitations, and pain radiating to the jaw, neck, back, or between the shoulder blades.
- Women are more likely to present without any chest pain at all, and this pattern increases with age and with diabetes, which blunts symptom perception through autonomic neuropathy.
- Prodromal symptoms — profound fatigue and sleep disturbance in the weeks before an event — are reported more often by women.
The consequences are measurable: longer symptom-to-door times, longer door-to-balloon times, and higher rates of initial misattribution to anxiety, reflux, or musculoskeletal causes.
| Feature | Pattern |
|---|---|
| Most common symptom, both sexes | Chest pain or discomfort |
| More common in women | Dyspnea, nausea, fatigue, jaw/neck/back pain, diaphoresis |
| Painless presentation | More common in women, older adults, and patients with diabetes |
| Time to presentation | Longer in women |
Ischemic Syndromes That Predominantly Affect Women
A CR professional will encounter patients whose angiogram showed no obstructive lesion but whose diagnosis is genuinely ischemic. These are not "normal hearts."
| Condition | Description | CR-relevant implications |
|---|---|---|
| MINOCA (myocardial infarction with non-obstructive coronary arteries) | Objective MI criteria with less than 50% stenosis on angiography; mechanisms include plaque disruption, embolism, spasm, and microvascular dysfunction | A true MI and a qualifying CR diagnosis; patients often arrive believing nothing was wrong |
| SCAD (spontaneous coronary artery dissection) | Non-atherosclerotic separation of the arterial wall; strongly female-predominant, often younger, associated with fibromuscular dysplasia and the peripartum period | Frequently managed conservatively rather than with stenting; exercise progression is typically more cautious, commonly avoiding maximal isometric and very high-intensity efforts, and extreme emotional stress is an identified trigger |
| INOCA / coronary microvascular dysfunction | Ischemia and angina without obstructive epicardial disease, due to impaired microvascular vasodilation | Angina may occur at low workloads with a normal-appearing catheterization report; symptoms are real and should not be dismissed |
| Takotsubo (stress) cardiomyopathy | Acute apical ballooning with transient systolic dysfunction, typically after intense emotional or physical stress; strongly predominant in postmenopausal women | Ventricular function usually recovers over weeks; exercise progression follows recovery of function, and psychosocial intervention is central rather than adjunctive |
Referral, Enrollment, and Completion Disparities
Women derive at least equivalent mortality and functional benefit from cardiac rehabilitation, yet at every stage of the pipeline they fall out at higher rates:
- Referral — physicians refer women less often after qualifying events.
- Enrollment — among those referred, women enroll less often.
- Completion — among those enrolled, women complete fewer sessions.
Contributing factors include caregiving obligations that conflict with daytime programming, transportation, greater age and comorbidity at presentation, lower physician endorsement strength, depression, and program environments that feel male-oriented. Practical countermeasures include automatic referral protocols that remove individual physician discretion, flexible or hybrid scheduling, women-focused session times or groups, and explicit attention to psychosocial screening, where women screen positive for depression at higher rates.
Similar under-referral and under-enrollment patterns are documented for Black and Hispanic patients, persisting after adjustment for insurance status.
Race, Ancestry, and Treatment Response
A limited set of guideline-recognized differences are directly testable:
Hypertension in Black adults
- Higher prevalence, earlier onset, and greater severity of hypertension, with higher rates of associated stroke, heart failure, and end-stage kidney disease.
- Initial pharmacotherapy: for Black adults with hypertension and without heart failure or chronic kidney disease, ACC/AHA guidance favors a thiazide-type diuretic or a calcium channel blocker as first-line therapy, based on greater average blood pressure lowering.
- ACE inhibitors carry a substantially higher risk of angioedema in Black patients, and cough is also more frequent. A patient reporting lip or tongue swelling on an ACE inhibitor requires urgent evaluation and permanent discontinuation of the class.
- Greater average salt sensitivity makes sodium-reduction counseling especially high-yield.
Ancestry as a risk enhancer
The 2018 AHA/ACC cholesterol guideline identifies South Asian ancestry as a risk-enhancing factor — a finding that can tip a borderline- or intermediate-risk patient toward statin initiation or intensification during the clinician-patient risk discussion. South Asian populations show elevated ASCVD risk at lower BMI thresholds, which also informs interpretation of anthropometric measurements.
Diabetes and obesity prevalence
Hispanic/Latino and American Indian/Alaska Native populations carry higher diabetes prevalence, and multiple Asian subpopulations develop type 2 diabetes at lower BMI values, which is why the ADA recommends screening Asian American adults at a BMI of 23 kg/m² or greater rather than the general threshold of 25.
Realistic Clinical Scenario
Scenario: A 44-year-old woman, 5 months postpartum, is referred to Phase II after a myocardial infarction attributed to spontaneous coronary artery dissection, managed medically without stenting. At intake she says, "They told me my arteries were clean, so I'm not sure why I'm here." She reports fatigue and intermittent chest discomfort with emotional stress. Her PHQ-9 is 12.
Assessment: SCAD is a genuine myocardial infarction and a legitimate CR indication; the absence of atherosclerotic obstruction does not mean the event was benign. The patient's misunderstanding is common and warrants direct correction. Moderate depressive symptoms are present, and emotional stress is a recognized SCAD trigger, making psychosocial care a primary rather than peripheral component.
Plan: Explain the diagnosis explicitly and validate that her event was real. Coordinate the exercise prescription with the treating cardiologist, expecting a more conservative progression than a typical post-PCI patient, with attention to avoiding maximal isometric effort, heavy Valsalva-generating loads, and very high-intensity exertion until cleared. Prioritize stress management and refer for behavioral health evaluation given the PHQ-9 of 12. Reinforce that her chest discomfort should be reported rather than dismissed, and document symptom patterns to share with the cardiology team.
Which statement most accurately describes sex differences in acute coronary syndrome presentation?
A 61-year-old Black patient with stage 2 hypertension has no heart failure and no chronic kidney disease. According to ACC/AHA guidance, which initial pharmacologic approach is preferred, and which adverse effect warrants specific counseling?
A 46-year-old woman is referred after an MI attributed to spontaneous coronary artery dissection managed without stenting. Which combination of statements is correct?